{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:58:25Z","timestamp":1791097105556,"version":"4.1.0"},"reference-count":25,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"abstract":"<jats:p>Invasive aspergillosis is extremely rare in immunocompetent children. Here we describe the clinical, radiologic, and laboratory course of fatal invasive pulmonary and central nervous system aspergillosis in a previously healthy child after a near-drowning incident with submersion in a pond. Findings were compared with data from the literature, which is reviewed. Serum Aspergillus galactomannan levels were determined retrospectively and were compared with the results of routine microbiological and radiologic examinations, showing a significant diagnostic and therapeutic delay of the routine diagnostic approach in comparison with the use of the Aspergillus galactomannan assay. This delay may have contributed to the fatal course. Serial determination of serum Aspergillus galactomannan may be helpful in diagnosing invasive aspergillosis early in case of pulmonary disease after near-drowning and may contribute to an early appropriate treatment. Currently voriconazole, eventually in combination with caspofungin, should be considered as the drug of choice in the management of invasive aspergillosis after near-drowning.<\/jats:p>","DOI":"10.1542\/peds.2005-2901","type":"journal-article","created":{"date-parts":[[2006,7,25]],"date-time":"2006-07-25T00:24:51Z","timestamp":1153787091000},"page":"e509-e513","source":"Crossref","is-referenced-by-count":42,"title":["Invasive Pulmonary and Central Nervous System Aspergillosis After Near-Drowning of a Child: Case Report and Review of the Literature"],"prefix":"10.1542","volume":"118","author":[{"given":"Piet","family":"Leroy","sequence":"first","affiliation":[{"name":"Divisions of Pediatric Intensive Care"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Smismans","sequence":"additional","affiliation":[{"name":"Medical Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Seute","sequence":"additional","affiliation":[{"name":"Pediatric Neurology, University Hospital Maastricht, Maastricht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,8,1]]},"reference":[{"key":"2021120822394028100_R1","doi-asserted-by":"crossref","unstructured":"Steinbach WJ. Pediatric aspergillosis: disease and treatment differences in children. Pediatr Infect Dis J.\u20082005;24:358\u2013364","DOI":"10.1097\/01.inf.0000157218.37603.84"},{"key":"2021120822394028100_R2","doi-asserted-by":"crossref","unstructured":"Ender PT, Dolan MJ. Pneumonia after near-drowning. Clin Infect Dis.\u20081997;25:896\u2013907","DOI":"10.1086\/515532"},{"key":"2021120822394028100_R3","doi-asserted-by":"crossref","unstructured":"ter Maaten JC, Golding RP, Strack van Schijndel RJ, Thijs LG. Disseminated aspergillosis after near-drowning. Neth J Med.\u20081995;47:21\u201324","DOI":"10.1016\/0300-2977(94)00102-F"},{"key":"2021120822394028100_R4","doi-asserted-by":"crossref","unstructured":"Kowacs PA, Monteiro de Almeida S, Pinheiro RL, et al. Central nervous system Aspergillus fumigatus infection after near drowning. J Clin Pathol.\u20082004;57:202\u2013204","DOI":"10.1136\/jcp.2003.010066"},{"key":"2021120822394028100_R5","doi-asserted-by":"crossref","unstructured":"Suominen P, Baillie C, Korpela R, Rautanen S, Ranta S, Olkkola KT. Impact of age, submersion time and water temperature on outcome in near-drowning. Resuscitation.\u20082002;52:247\u2013254","DOI":"10.1016\/S0300-9572(01)00478-6"},{"key":"2021120822394028100_R6","unstructured":"Crowe S, Mannion D, Healy M, O'Hare B, Lyons B. Paediatric near-drowning: mortality and outcome in a temperate climate. Ir Med J.\u20082003;96:274\u2013276"},{"key":"2021120822394028100_R7","doi-asserted-by":"crossref","unstructured":"Lin SJ, Schranz J, Teutsch SM. Aspergillosis case fatality rate: systematic review of the literature. Clin Infect Dis.\u20082001;32:358\u2013366","DOI":"10.1086\/318483"},{"key":"2021120822394028100_R8","doi-asserted-by":"crossref","unstructured":"von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration.\u20081995;62:341\u2013347","DOI":"10.1159\/000196477"},{"key":"2021120822394028100_R9","doi-asserted-by":"crossref","unstructured":"Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology.\u20081985;157:611\u2013614","DOI":"10.1148\/radiology.157.3.3864189"},{"key":"2021120822394028100_R10","doi-asserted-by":"crossref","unstructured":"Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis.\u20082002;186:1297\u20131306","DOI":"10.1086\/343804"},{"key":"2021120822394028100_R11","doi-asserted-by":"crossref","unstructured":"Mennink-Kersten MA, Klont RR, Warris A, Op den Camp HJ, Verweij PE. Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection. Lancet.\u20082004;363:325\u2013327","DOI":"10.1016\/S0140-6736(03)15393-7"},{"key":"2021120822394028100_R12","unstructured":"Warris A, Abrahamsen TG, Breuker IM, Meis JF, Gaustad P, Verweij PE. Fungal antigenemia in premature neonates due to the presence of galactomannan and mannan in milk formulas [abstract]. Presented at: 41st annual Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, IL; December16-19, 2001. Abstract J-848"},{"key":"2021120822394028100_R13","doi-asserted-by":"crossref","unstructured":"Singh N, Obman A, Husain S, Aspinall S, Mietzner S, Stout JE. Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother.\u20082004;48:1989\u20131992","DOI":"10.1128\/AAC.48.6.1989-1992.2004"},{"key":"2021120822394028100_R14","doi-asserted-by":"crossref","unstructured":"Maertens J, Theunissen K, Verhoef G, Van Eldere J. False-positive Aspergillus galactomannan antigen test results. Clin Infect Dis.\u20082004;39:289\u2013290","DOI":"10.1086\/422151"},{"key":"2021120822394028100_R15","doi-asserted-by":"crossref","unstructured":"Garnacho-Montero J, Amaya-Villar R, Ortiz-Leiba C, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care.\u20082005;9:R191\u2013R199","DOI":"10.1186\/cc3488"},{"key":"2021120822394028100_R16","doi-asserted-by":"crossref","unstructured":"Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis.\u20082001;33:1824\u20131833","DOI":"10.1086\/323900"},{"key":"2021120822394028100_R17","doi-asserted-by":"crossref","unstructured":"Palanisamy A, Chao SD, Fouts M, Kerr D. Central nervous system aspergillosis in an immunocompetent patient: cure in a hospice setting with very high-dose itraconazole. Am J Hosp Palliat Care.\u20082005;22:139\u2013144","DOI":"10.1177\/104990910502200212"},{"key":"2021120822394028100_R18","doi-asserted-by":"crossref","unstructured":"Tattevin P, Bruneel F, Lellouche F, et al. Successful treatment of brain aspergillosis with voriconazole. Clin Microbiol Infect.\u20082004;10:928\u2013931","DOI":"10.1111\/j.1469-0691.2004.00981.x"},{"key":"2021120822394028100_R19","doi-asserted-by":"crossref","unstructured":"Schwartz S, Ruhnke M, Ribaud P, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood.\u20082005;106:2641\u20132645","DOI":"10.1182\/blood-2005-02-0733"},{"key":"2021120822394028100_R20","unstructured":"Schwartz S, Thiel E. Update on the treatment of cerebral aspergillosis. Ann Hematol.\u20082004;83(suppl 1):S42\u2013S44"},{"key":"2021120822394028100_R21","doi-asserted-by":"crossref","unstructured":"Walsh TJ, Lutsar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis, and other invasive fungal infections in children. Pediatr Infect Dis J.\u20082002;21:240\u2013248","DOI":"10.1097\/00006454-200203000-00015"},{"key":"2021120822394028100_R22","doi-asserted-by":"crossref","unstructured":"Clemons KV, Espiritu M, Parmar R, Stevens DA. Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrob Agents Chemother.\u20082005;49:4867\u20134875","DOI":"10.1128\/AAC.49.12.4867-4875.2005"},{"key":"2021120822394028100_R23","unstructured":"Cancidas (caspofungin acetate) for injection [package insert]. Whitehouse Station, NJ: Merck & Co, Inc; 2004. Available at: www.fda.gov\/MedWatch\/SAFETY\/2004\/mar_PI\/Cancidas_PI.pdf. Accessed December 1, 2003"},{"key":"2021120822394028100_R24","doi-asserted-by":"crossref","unstructured":"Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis.\u20082004;39:797\u2013302","DOI":"10.1086\/423380"},{"key":"2021120822394028100_R25","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Marco F, Messer SA, Jones RN. In vitro activity of two echinocanin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis.\u20081998;30:251\u2013255","DOI":"10.1016\/S0732-8893(97)00246-0"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e509\/1074553\/zpe0080600e509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e509\/1074553\/zpe0080600e509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T02:25:47Z","timestamp":1639016747000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/2\/e509\/68979\/Invasive-Pulmonary-and-Central-Nervous-System"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,8,1]]},"published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-2901","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}